Manel E. Juan
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 177 publications
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Journal: Expert opinion on investigational drugs
Published: July 30, 2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Journal: Expert opinion on investigational drugs
Published: July 30, 2026
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Journal: Journal for immunotherapy of cancer
Published: July 08, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT.
Journal: Annals of hematology
Published: March 30, 2026
Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ-Specific B Cells.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 13, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement.
Journal: British journal of haematology
Published: March 09, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain.
Journal: Journal for immunotherapy of cancer
Published: February 10, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.
Journal: HemaSphere
Published: December 28, 2025
Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung.
Journal: European journal of pharmacology
Published: October 27, 2025
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: October 06, 2025
Specific Instability of HLA-A*03:01 Expression in HEK-293 Cells.
Journal: International journal of molecular sciences
Published: October 01, 2025
Last Updated: 09/26/2026